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1  | INTRODUCTION
Gastrointestinal infections can lead to long‐term complications after 
the microbial agent has been eradicated. Post‐infectious irritable 
bowel syndrome (PI‐IBS) has been recognized for decades1 and is 
clinically similar to sporadic irritable bowel syndrome (IBS). Chronic 
fatigue syndrome (CFS) is another known condition following some 
infections,2 including giardiasis.3,4 Chronic fatigue (CF) is a useful 
and validated concept in epidemiologic studies where clinical exami‐
nation is not feasible.5 CF has also been found to be a long‐lasting 
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Abstract
Background: Gastroenteritis has been associated with complications such as irritable 
bowel syndrome (IBS) and chronic fatigue (CF). Little is known about the implications 
for quality of life (QoL) in this setting. The aims of this study were to evaluate the as‐
sociation between exposure to Giardia infection and QoL ten years after the infec‐
tion, and how this related to IBS and CF.
Methods: We followed 1252 patients with laboratory‐verified Giardia lamblia infec‐
tion and a matched control group for 10 years after an epidemic in Bergen, Norway, 
in 2004. The main outcome was QoL after ten years as defined by the Short‐form 12 
version 2 with a physical component summary (PCS) and a mental component sum‐
mary (MCS), both with range 0‐100 (T‐score). Regression analyses were performed 
using mixed modeling.
Key Results: Mean PCS T‐score in the exposed group (51.4; 95% CI: 50.6‐52.1) was 
2.8	T‐score	points	 (95%	CI:	−3.8	 to	−1.9,	P < 0.001) lower than that in the control 
group (54.2; 95% CI: 53.7‐54.8). The mean MCS T‐score was also 2.8 T‐score points 
(95%	CI:	−3.8	to	−1.9,	P < 0.001) lower among the exposed (48.9; 95% CI: 48.2‐49.6) 
than the controls (51.7; 95% CI: 51.1‐52.4). Further analyses found that the effect of 
Giardia exposure on QoL was mediated by IBS and CF.
Conclusions & Inferences: Exposure	to	Giardia infection was associated with a lower 
QoL ten years later as compared to a control group, an effect that was mediated by 
IBS and CF.
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complication after giardiasis.6–8 Few studies have investigated qual‐
ity	 of	 life	 (QoL)	 after	 gastrointestinal	 infections.	One	 study	 found	
that QoL was impaired six months after Shiga toxin‐producing 
Escherichia coli gastroenteritis, and that the physical QoL normalized 
after one year, whereas the mental QoL remained impaired.9 CFS 
and IBS have been shown to affect QoL.10‐14
In 2004, one of the main drinking‐water reservoirs of the city of 
Bergen, Norway, was contaminated by Giardia lamblia cysts. IBS and 
CF were associated with exposure to Giardia infection as long as ten 
years after the outbreak,6 but how this may affect QoL is not well 
known. The main aim of this study was to evaluate the association 
between exposure to Giardia infection and QoL ten years after the 
Bergen outbreak, as compared to a control group. The secondary 




This was a prospective cohort study following 1252 infected patients 
with laboratory‐verified Giardia lamblia (the exposed group) and a 
control group three, six, and ten years after an epidemic of giardiasis 
in Bergen, Norway, 2004. The group of 2504 controls was matched 
2:1 by sex and age to the exposed group and was recruited from the 
Bergen area by Statistics Norway, on our request. We only included 
participants who were 18 years or older in 2014 for this study.
Patients consented to participate upon answering the question‐
naire.	The	Regional	Committee	 for	Ethics	 in	Medical	Research	ap‐
proved the study (ref.no. 2014/1372).
2.2 | Variables
Health‐related	QoL	was	the	main	outcome	of	the	study,	as	meas‐
ured by the Short‐form 12 version 2 (SF‐12v2). The SF‐12v2 
consists of a physical component summary (PCS) and a mental 
component summary (MCS), measuring physical and mental QoL, 
respectively. The PCS and MCS range from 0‐100 and are based 
on a 2009 US norm for QoL with a mean of 50 and a standard 
deviation of 10. The points on the scale are referred to as T‐score 
points. The two scores are based on the score of eight sub‐scales, 
that is, physical functioning, role‐physical (how the physical QoL 
affects daily functioning), bodily pain, general health, vitality, so‐
cial functioning, role‐emotional (how the mental QoL affects daily 
functioning),	and	mental	health.	Although	all	eight	sub‐scales	con‐
tribute to the scoring of both PCS and MCS, the former three have 
the strongest correlation with PCS, and the latter three have the 
strongest	 correlation	with	MCS.	 Also,	 the	 use	 of	 an	 orthogonal	
scoring algorithm applies negative weights to sub‐scales most 
strongly correlated with MCS when scoring the PCS (and vice 
versa), ensuring validity in discriminating between physical and 
mental health outcomes. In addition, PCS and MCS scores were 
both dichotomized based on a score of 45 and above, or lower than 
45. Scoring of the QoL variables was done using the QualityMetric 
Health	Outcomes™	Scoring	Software	5.0,	as	recommended	by	the	
developers of the SF‐12.15 The software’s option to estimate miss‐
ing scores was used. We used PCS and MCS means and stand‐
ard deviations from Gandek et al16 to compare our results with 
a Norwegian norm. The SF‐12 was translated to Norwegian and 
validated for use on a Norwegian population as part of that study. 
The developers of the SF‐12 suggest that when comparing QoL 
between groups, a difference in three or more T‐score points is 
considered clinically important.15
IBS was defined according to the Rome‐III criteria.17 Respondents 
were defined as having IBS if reporting recurrent abdominal pain or 
discomfort for at least three days per month in the last three months, 
associated with at least two or more of the additional IBS‐criteria 
related to defecation or stool changes, if onset of symptoms was at 
least 6 months prior to completing the questionnaire.
CF was defined using the Fatigue Questionnaire.5 This validated 
questionnaire consists of 13 questions, where 11 of these measure 
different aspects of fatigue on a four‐item Likert scale: “less than 
usual” (0), “as usual” (1), “more than usual” (2), and “much more than 
usual” (3). The sum of these scores constitutes the total fatigue score 
with a range of 0‐33. The Likert scale scores are also dichotomized 
(0 and 1 into 0, 2 and 3 into 1), and CF is defined as a dichotomized 
score of four or more and a duration of six months or more. Cases 
with 4 or less missing answers on the 11 fatigue‐related questions 
were included, and the missing responses for the questions were 
estimated based on the average for non‐missing responses to that 
particular question.
IBS and CF were assessed at follow‐ups of 3, 6, and 10 years 
after the outbreak, whereas QoL was assessed only at the 10‐year 
follow‐up.
To better assess and illustrate the relationships between ex‐
posure status, IBS and CF (all dichotomous), and the outcomes 
PCS and MCS, the three former variables were combined into 
one eight‐category variable with the categories “Neither condi‐
tion among controls” (reference category in regression analyses), 
“Neither condition among exposed”, “IBS‐only among controls”, 
“IBS‐only among exposed”, “CF‐only among controls”, “CF‐only 
Key Points
• Irritable bowel syndrome (IBS) and fatigue are known 
complications following gastroenteritis. This paper as‐
sessed the quality of life ten years after a Giardia lamblia 
gastroenteritis and how this related to IBS and fatigue.
• Quality of life was lower among patients who suffered 
from gastroenteritis, mainly due to the development of 
IBS and fatigue.
• Clinicians should be aware that gastroenteritis can have 
a lasting impact on quality of life in patients, especially in 
those who have long‐term complications.
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among exposed”, “IBS and CF among controls”, and “IBS and CF 
among exposed”.
Demographic	 variables	 recorded	 were	 sex	 (dichotomous),	 age	
(continuous and categorized according to the SF12v2 user’s man‐
ual15), marital status (four categories), level of education (three cate‐
gories), and source of income (four categories).
2.3 | Analyses and statistical methods
We calculated descriptive statistics as percentage, mean, standard 
deviation	(SD),	and	95%	confidence	intervals	(CI).	We	used	Fisher’s	
exact 2‐sided mid‐p test in 2 × 2 tables for binary outcomes18 and 
Pearson’s chi‐square exact 2‐sided test for multilevel outcomes.
To account for dependence between matched subjects, we used 
mixed modeling with unstructured covariance when performing re‐
gression analyses.
All	means	presented	are	the	observed	means,	to	give	the	reader	
the unadjusted values of PCS and MCS for the different study 
groups.	 All	 differences	 between	 means	 presented	 are	 estimated,	
as they are the results of regression analyses, and hence, they do 





P‐valuebn %a n %a
Response rate 592/1176 50.3 708/2330 30.4
Female sex 395 66.9 455 65.4 NAc
Age	in	years
Mean/range 42.9d 18‐88d 43.6d 18‐89d NAc
18‐24 12 2.0 9 1.3 NAc
25‐34 174 29.5 184 26.4
35‐44 189 32.0 258 37.1
45‐54 103 17.5 98 14.1
55‐64 72 12.2 88 12.6
65‐74 32 5.4 44 6.3
75‐89 8 1.4 15 2.2
Marital status
Single 124 21.1 113 16.3 0.04
Married 423 71.9 536 77.1
Divorced 35 6.0 32 4.6
Widowed 6 1.0 14 2.0
Education
Primary school 23 3.9 31 4.5 0.31
Secondary school 128 21.9 172 25.1
University 434 74.2 481 70.3
Main occupation
Worker 478 81.2 580 83.6 0.30
Student 16 2.7 16 2.3
Unemployed/
retired
78 13.2 88 12.7
Other 17 2.9 10 1.4
IBS prevalence 248 43.1 94 13.7 <0.001
CF prevalence 153 26.1 73 10.5 <0.001
CF, chronic fatigue; IBS, irritable bowel syndrome.
aPercentages may not total to 100 because of rounding. 
bPearson’s chi‐squared exact 2‐sided, except for IBS and CF (Fisher’s exact 2‐sided mid‐p). 
cNA	=	not	applicable;	respondents	were	matched	on	sex	and	age,	and	hence,	we	did	not	perform	
significance testing for these variables. 
dMean age, age range. 
TA B L E  1   Response rate, 
demographics, and prevalence of irritable 
bowel syndrome and chronic fatigue of 
the cohorts ten years after a Giardia 
lamblia outbreak in Bergen, Norway, in 
2004
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Confounding was evaluated with regression analyses. Level of 
education, source of income, and marital status were considered 
potential confounders. Sex and age were matched for and hence 
were not considered potential confounders. Possible interactions 




set to 0.05. The analyses were done using IBM SPSS Statistics for 
Windows,	version	25.0	(IBM	Corp,	Armonk,	NY,	USA).
3  | RESULTS
Response rate, demographic data, prevalence of IBS and CF, and 
non‐responder analyses of this cohort ten years after the Giardia 
outbreak have been published previously,6 and some of these data 
are summarized in Table 1. For PCS, there were 0.3% missing values 
among exposed (2/590) and 0.9% missing among controls (6/696). 
For MCS, there were no missing values. For IBS, there were 14 miss‐
ing out of 590 (2.4%) among exposed and 11 of 696 (1.6%) among 
controls. For CF, the corresponding numbers were 3/590 (0.5%) and 
4/696 (0.6%), respectively.
Mean QoL T‐score for the entire cohort regardless of group was 
52.9	(SD:	8.7)	for	PCS	and	50.4	(SD:	9.1)	for	MCS.
Mean PCS T‐score in the exposed group (51.4; 95% CI: 50.6‐52.1) 
was	2.8	T‐score	points	(95%	CI:	−3.8	to	−1.9;	P < 0.001) lower than 
for the control group (54.2; 95% CI: 53.7‐54.8). The mean MCS T‐
score	was	also	2.8	T‐score	points	 (95%	CI:	−3.8	 to	−1.9,	P < 0.001) 
lower among the exposed (48.9; 95% CI: 48.2‐49.6) than the controls 
(51.7; 95% CI: 51.1‐52.4; Figure 1).
“Neither condition among controls” (after ten years) was the ref‐
erence category in regression analyses and was the subgroup with 
the highest QoL for both PCS and MCS (Tables 2 and 3), with mean 
T‐scores of 55.4 (95% CI: 54.9‐55.9) and 53.4 (95% CI: 52.8‐54.0), 
respectively. The exposed with neither condition after ten years 
had	the	same	PCS	(mean	T‐score	difference:	−0.1;	95%	CI:	−1.2	to	
1.0; P‐value:	0.84),	but	a	lower	MCS	(mean	T‐score	difference:	−1.4;	
95%	CI:	−2.5	to	−0.2;	P‐value: 0.023) than the reference category. 
All	other	categories	 in	the	eight‐category	variable	described	in	the	
methods section had a lower QoL than the reference category, both 
for PCS and for MCS. This eight‐category variable was also analyzed 
with PCS and MCS as a dichotomized outcome with a T‐score below 
45	points	or	not	(Tables	2	and	3).	Over	50%	of	the	respondents	in	
the category “IBS and CF among exposed” had a PCS lower than 
45 points. For MCS, all categories comprising respondents with CF‐
only or CF and IBS had over 50% of respondents with an MCS score 
below 45.
In a regression model with exposure status, IBS and CF after ten 
years as independent variables, and PCS as the outcome, there was 
F I G U R E  1  Observed	mean	PCS	and	MCS	with	95%	confidence	intervals	10	years	after	a	Giardia	lamblia	outbreak	in	Bergen,	Norway,	
in 2004, as compared to a Norwegian Norma. PCS, physical component summary; MCS, mental component summary; IBS, irritable bowel 
syndrome;	CF,	chronic	fatigue;	Con,	controls;	Exp,	exposed	to	Giardia. aSF‐12 scores for a Norwegian sample population from Gandek et al.16 
The horizontal lines on the figure are one‐third of a standard deviation T‐score points under/over the mean T‐score from that population. 
Dotted	for	MCS,	solid	for	PCS.	bThe first four columns (with bold labels) depict PCS and MCS according to exposure status. The next sixteen 
columns depict PCS and MCS according to the eight‐category variable described in the methods section
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no longer a significant effect of exposure status on the outcome with 
a mean PCS that was 0.50 T‐score points lower among the exposed 
(95%	CI:	−1.4	to	0.40;	P‐value: 0.28). The same was found for mean 
MCS, which was 0.75 T‐score points lower among the exposed (95% 
CI:	−1.7	to	0.22;	P‐value: 0.13).
We found a significant interaction between CF and exposure 
status on both measures of QoL (Table 4). The mean PCS among 
those	with	CF	in	the	exposed	group	was	−9.2	points	lower	than	for	
respondents without CF, whereas for controls, the difference was 
−4.7	 (P < 0.001). For MCS, the relationship was inverse: The mean 
MCS	among	those	with	CF	 in	the	control	group	was	−10.9	T‐score	
points lower than for respondents without CF, whereas for exposed, 
the	difference	was	−8.0	(P‐value: 0.027). We found no significant in‐
teraction between IBS and exposure on QoL (P‐value: 0.78 for PCS; 
P‐value: 0.34 for MCS).
We found no interactions of sex on the association between ex‐
posure and PCS (P‐value: 0.16) or MCS (P‐value: 0.39), nor of age on 
the same associations (P‐values: 0.10 and 0.056, respectively).
We also analyzed how exposure status, IBS and CF after three 
and six years related to QoL after ten years (Table S1). We found 
that for the eight‐category variable with “Neither condition among 
controls” at each follow‐up as reference category, the findings (in 
terms of direction and statistical significance of the results) were 
similar to the results above (after ten years) with some exceptions. 
In addition to the category, “Neither condition among exposed” also 
the category “IBS‐only among controls” after six years had the same 
PCS as the reference category. The categories “Neither condition 
among exposed” and “IBS‐only among controls” after both three and 
six years had the same MCS after ten years as the reference cate‐
gory. Corresponding analyses on dichotomized PCS and MCS after 
TA B L E  2   Quality of life, physical component summary analyzed by simple regression analyses, as continuous and dichotomized variable 





n % OR 95% CI
Neither condition among 
controls
532 55.4a 54.9 to 55.9 ref 35 6.6 ref ref
Neither condition among 
exposed
280 −0.1 −1.2	to	1.0 0.84 18 6.4 1.0 0.6‐1.8
IBS‐only among controls 75 −4.4 −6.2	to	−2.5 <0.001 17 22.7 4.4 2.3‐8.3
IBS‐only among exposed 146 −3.3 −4.7	to	−1.9 <0.001 20 13.7 2.4 1.3‐4.3
CF‐only among controls 50 −5.1 −7.3	to	−2.9 <0.001 16 32.0 6.1 3.0‐12.2
CF‐only among exposed 45 −8.6 −10.9	to	−6.2 <0.001 22 48.9 14.0 7.1‐27.6
IBS and CF among controls 18 −7.5 −11.0	to	−3.9 <0.001 6 33.3 6.9 2.4‐20.2
IBS and CF among exposed 101 −13.1 −14.8	to	−11.5 <0.001 55 54.5 17.4 10.3‐29.5
CF, chronic fatigue; IBS, irritable bowel syndrome; PCS, physical component summary; Ref, reference group.
aMean in reference group of eight‐category exposure variable. 
TA B L E  3   Quality of life, mental component summary analyzed by simple regression analyses, as continuous and dichotomized variable 





n % OR 95% CI
Neither condition among 
controls
536 53.4a 52.8 to 54.0 ref 67 12.5 ref ref
Neither condition among 
exposed
282 −1.4 −2.5	to	−0.2 0.023 50 17.7 1.6 1.0‐2.3
IBS‐only among controls 75 −3.8 −5.8	to	−1.8 <0.001 15 20.0 1.7 0.9‐3.3
IBS‐only among exposed 146 −3.6 −5.1	to	−2.1 <0.001 33 22.6 2.1 1.3‐3.3
CF‐only among controls 51 −12.3 −14.7	to	−10.0 <0.001 30 58.8 9.6 5.2‐17.8
CF‐only among exposed 45 −9.8 −12.2	to	−7.3 <0.001 23 51.1 7.6 4.0‐14.4
IBS and CF among controls 19 −10.1 −13.8	to	−6.3 <0.001 13 68.4 15.9 5.9‐43.1
IBS and CF among exposed 101 −11.5 −13.3	to	−9.8 <0.001 62 61.4 11.4 7.1‐18.4
CF, chronic fatigue; IBS, irritable bowel syndrome; MCS, mental component summary; Ref, reference group.
aMean in reference group of eight‐category exposure variable. 
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three and six years are found in Table S2. The effect of exposure on 
QoL after ten years was absent when controlling for IBS and CF after 
three and six years in a regression model, with the exception of the 
analysis after 6 years, where MCS after ten years was significantly 
reduced when controlling for IBS and CF after 6 years. The interac‐
tion between exposure and CF on QoL was not found after three or 
six years (Table S3).
Scores on the sub‐scales most strongly associated with MCS were 
assessed descriptively to further elucidate the above‐mentioned in‐
teraction between exposure status and CF on QoL (Table S4). The 
“vitality” subdomain had the lowest score, but this was rather similar 
between exposed and controls with CF‐only (mean T‐score 38.1 vs 
38.4). The subdomain “mental health” was lower among controls with 
CF‐only (44.9) than among exposed with CF‐only (48.2).
We found no confounding of our results by the demographic 
variables marital status, level of education, and source of income.
4  | DISCUSSION
We found a lower QoL among giardiasis‐exposed persons ten years 
after the exposure, as compared to a control group. This effect of 
the exposure to giardiasis on QoL was mediated by IBS and CF. For 
the association between exposure and QoL, there was an interaction 
between CF and exposure, as the reduction of physical QoL due to 
CF was larger among exposed than controls. The opposite was found 
for mental QoL.
4.1 | Interpretation
We found that exposure to Giardia lamblia was associated with a 
lower	QoL	ten	years	later	as	compared	to	a	control	group.	However,	
the difference between the exposed and the controls for both PCS 
and MCS at 2.8 T‐score points was below the proposed thresh‐
old of 3 T‐score points that is considered clinically significant. The 
mean PCS for the control cohort was higher than the norm for the 
Norwegian population, whereas the mean PCS among exposed and 
the mean MCS regardless of exposure group were clinically similar to 
this norm.16 This may in part be explained by the fact that our study 
population is relatively young. There is a slight decrease in PCS with 
age in normal populations, whereas MCS increases somewhat.16
Exposed	who	had	neither	condition	had	a	similar	PCS	to	con‐
trols with neither condition, whereas the MCS was slightly lower 
for	 the	 exposed.	However,	 both	 these	 groups	 had	 a	QoL	 higher	
than or equal to a Norwegian population norm. We found a trend 
that the presence of IBS alone lowered the QoL in both the ex‐
posed and control group, but less than CF alone did. The lowest 
QoL was found among exposed with both IBS and CF, both for 
PCS (42.2) and for MCS (41.9), as well as for CF‐only among con‐
trols, with an MCS of 41.1. The PCS at 42.2 is comparable to that 
found in other conditions such as type 2 diabetes and recent myo‐
cardial infarction.19 The MCS scores in the two above‐mentioned 
groups	 were	 lower	 than	 the	 cutoff	 at	 ≤42	T‐score	 points	 used	
to classify people as being at risk for clinical depression in one 
study.20 Respondents with IBS‐only had a QoL comparable to a 
TA B L E  4   Physical component summary and mental component summary according to chronic fatigue status at ten years follow‐up, in 
exposed and control cohorts of the Giardia lamblia outbreak in Bergen, Norway, in 2004a







PCS Exposed Yes 146 43.7 41.7 45.6 <0.001 −4.5
No 426 54.2 53.5 54.8
Differenced −9.2 −10.7 −7.7
Control Yes 68 49.7 47.1 52.2
No 607 54.8 54.3 55.4
Differenced −4.7 −6.6 −2.7
MCS Exposed Yes 146 42.4 40.9 43.9 0.027 2.9
No 428 51.3 50.5 52.0
Differenced −8.0 −9.6 −6.4
Control Yes 70 41.7 39.3 44.1
No 611 52.9 52.3 53.6
Differenced −10.9 −12.9 −8.9
CF, chronic fatigue; CI, confidence interval; MCS, mental component summary (0‐100); PCS, physical component summary (0‐100).
aIn a linear regression model including the factors cohort (exposed/control), irritable bowel syndrome (yes/no), CF (yes/no), and the interaction term 
cohort ×CF. 
bInteraction between cohort and CF on the outcomes PCS and MCS. 
cThe difference in quality of life between CF and no CF among exposed, minus that among controls. 
dMeans	are	observed,	with	CI.	Differences	are	estimated	in	a	mixed	linear	model	and	hence	do	not	necessarily	equal	observed	mean	value	for	CF	minus	
mean value for no CF. 
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Norwegian norm regardless of exposure status and comparable to 
a subgroup of IBS patients with low IBS‐symptom severity and no 
comorbidities in another study on IBS and QoL.10 The PCS of the 
respondents with IBS‐only in our study is also comparable to that 
of a group of IBS non‐consulters in a study by Rey et al,21 whereas 
the MCS is higher in our group. This could be explained by the 
fact that we have subgrouped our respondents into neither condi‐
tion, IBS‐only, CF‐only or a combination of the two conditions. The 
MCS among respondents with IBS dropped markedly when they 
have comorbid CF, to a level comparable to that of Rey et al’s IBS 
non‐consulters where CF comorbidity is unknown.
The fact that the effect of exposure status disappeared in mul‐
tiple regression analysis with IBS and CF included in the model sup‐
ports the choice of these conditions as clinically relevant markers of 
the consequences of the Giardia epidemic. IBS and CF can be seen as 
mediators of the effects of Giardia exposure on QoL.
We found an interaction by CF on the effects of exposure on 
QoL in that the reduction in PCS score among respondents due to 
CF was significantly larger among the exposed than among controls. 
For MCS, the relationship was opposite, the reduction was signifi‐
cantly	larger	among	controls	than	the	exposed	with	CF.	A	possible	
explanation for this could be that although both groups probably 
have a multifactorial cause for their CF, the respondents with CF 
among the exposed have a more specific organic etiology for their 
condition (ie, Giardia), whereas among controls mental factors could 
be more important. This notion is supported by the fact that the 
subdomain “mental health” was lower among controls with CF‐only, 
than among exposed with CF‐only (Table S4).
4.2 | Strengths and Limitations
One	strength	of	this	study	was	that	the	use	of	a	control	group	made	
the unfortunate event of an outbreak simulate a natural experiment. 
The number of participants in both groups was high, and all of the 
exposed had a laboratory‐confirmed diagnosis. The longitudinal as‐
pect of the study variables IBS and CF (measured after three, six, and 
ten years) makes causal inferences about the relationship between 
these conditions and QoL after ten years plausible. We used the 
validated SF‐12 to measure generic QoL. We performed the scor‐
ing using the developers recommended algorithm, with the 2009 
US norm. The fact that the measure is generic, widely used and has 
a standardized scoring algorithm, makes direct comparisons of our 
scores to other studies on various patient groups using the SF‐12 or 
SF‐36 possible.15
The response rate in the exposed group (50%) is a source of pos‐
sible bias, but is deemed acceptable and as expected for this kind 
of survey.22 The control group response rate is lower (30%), and we 
have made the case against selection bias in a previous study on the 
same cohort.6	 Also,	 recent	 research	 suggests	 that	 a	 declining	 re‐
sponse rate does not necessarily imply increasing bias in analyses of 
associations, although simple distributional data may suffer.22
The demographic variables recorded in our study (marital sta‐
tus, level of education, source of income) were measured after the 
exposure and hence could in part be affected by the exposure, mak‐
ing their role as confounders questionable.
QoL, IBS, and CF were all measured at the same time point, 
10 years after the exposure. This makes inferences about the re‐
lationships between these outcomes less certain. We therefore 
included results from analyses of IBS and CF measured at time‐
points three and six years after exposure and their effect on QoL 
after 10 years as well. In terms of direction of the effect and sta‐
tistical significance, the results from these analyses were generally 
similar to our main findings, except for the fact that the interaction 
between CF and exposure on QoL was only found after 10 years. 
Nevertheless, we believe that the longitudinal analyses support the 
notion of IBS and CF as causes of reduced QoL and justify discussing 
the role of IBS and CF as mediators of the effect of exposure on QoL, 
as well as CF as an interacting variable on the association between 
exposure status and QoL.
5  | CONCLUSION
We found a lower QoL among the exposed 10 years after giardiasis 
as compared to a control group, and this was mediated by IBS and CF. 
There was furthermore a significant interaction of CF on the associa‐
tion between the exposure and QoL. The effect of having CF in re‐
ducing the physical QoL was larger among the exposed than among 
controls, whereas for mental QoL, the opposite was found. The find‐
ings in this study support the importance of investigating whether 
patients suffer from PI‐IBS and CF after giardiasis, as these compli‐
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